Literature DB >> 21105946

Insuring against infertility: expanding state infertility mandates to include fertility preservation technology for cancer patients.

Daniel Basco1, Lisa Campo-Engelstein, Sarah Rodriguez.   

Abstract

In this paper, we recommend expanding infertility insurance mandates to people who may become infertile because of cancer treatments. Such an expansion would ensure cancer patients can receive fertility preservation technology (FPT) prior to commencing treatment. We base our proposal for extending coverage to cancer patients on the infertility mandate in Massachusetts because it is one of the most inclusive. While we use Massachusetts as a model, our arguments and analysis of possible routes to coverage can be applied to all states' seeking inclusive coverage for infertility treatment. Furthermore, our proposal can also be applied to people with other diseases who may be rendered infertile by treatment.
© 2010 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21105946      PMCID: PMC3097090          DOI: 10.1111/j.1748-720X.2010.00536.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  14 in total

1.  Coming to grips with the limitations of science: infertility and heredity in American history. [Reviews of: Marsh M; Ronner W. The empty cradle: infertility in America from colonial times to the present. Johns Hopkins University Press, 1996; and Paul DB. Controlling human heredity: 1865 to the present. Humanities Press, 1995].

Authors:  R Morantz-Sanchez
Journal:  Rev Am Hist       Date:  1997-06

2.  Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation.

Authors:  Lisa Campo-Engelstein
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

Review 3.  Medical hope, legal pitfalls: potential legal issues in the emerging field of oncofertility.

Authors:  Gregory Dolin; Dorothy E Roberts; Lina M Rodriguez; Teresa K Woodruff
Journal:  Cancer Treat Res       Date:  2010

4.  Frozen hope: fertility preservation for women with cancer.

Authors:  Gwendolyn P Quinn; Susan T Vadaparampil; Paul B Jacobsen; Caprice Knapp; David L Keefe; Geri E Bell
Journal:  J Midwifery Womens Health       Date:  2010 Mar-Apr       Impact factor: 2.388

Review 5.  Motivation for parenthood after cancer: a review.

Authors:  Leslie R Schover
Journal:  J Natl Cancer Inst Monogr       Date:  2005

Review 6.  The Oncofertility Consortium--addressing fertility in young people with cancer.

Authors:  Teresa K Woodruff
Journal:  Nat Rev Clin Oncol       Date:  2010-05-25       Impact factor: 66.675

7.  Reproductive gifts and gift giving: the altruistic woman.

Authors:  J G Raymond
Journal:  Hastings Cent Rep       Date:  1990 Nov-Dec       Impact factor: 2.683

Review 8.  Egg freezing: a breakthrough for reproductive autonomy?

Authors:  Karey Harwood
Journal:  Bioethics       Date:  2008-10-09       Impact factor: 1.898

Review 9.  Preservation of fertility in patients with cancer.

Authors:  Jacqueline S Jeruss; Teresa K Woodruff
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

10.  The economic cost of infertility-related services: an examination of the Massachusetts infertility insurance mandate.

Authors:  M Griffin; W F Panak
Journal:  Fertil Steril       Date:  1998-07       Impact factor: 7.329

View more
  11 in total

Review 1.  Engineered reproductive tissues.

Authors:  Emma S Gargus; Hunter B Rogers; Kelly E McKinnon; Maxwell E Edmonds; Teresa K Woodruff
Journal:  Nat Biomed Eng       Date:  2020-04-06       Impact factor: 25.671

2.  Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation.

Authors:  Lynae M Brayboy; Nathalie Oulhen; Jeannine Witmyer; Jared Robins; Sandra Carson; Gary M Wessel
Journal:  Fertil Steril       Date:  2013-08-13       Impact factor: 7.329

3.  Preserving the right to future children: an ethical case analysis.

Authors:  Gwendolyn P Quinn; Daniel K Stearsman; Lisa Campo-Engelstein; Devin Murphy
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

4.  Gametes or organs? How should we legally classify ovaries used for transplantation in the USA?

Authors:  Lisa Campo-Engelstein
Journal:  J Med Ethics       Date:  2011-01-18       Impact factor: 2.903

Review 5.  Fertility preservation in patients receiving cyclophosphamide therapy for renal disease.

Authors:  Radha Gajjar; Steven D Miller; Kevin E Meyers; Jill P Ginsberg
Journal:  Pediatr Nephrol       Date:  2014-09-05       Impact factor: 3.714

6.  The Landscape of Coverage for Fertility Preservation in Male Pediatric Patients.

Authors:  Molly Benoit; Kelly Chiles; Michael Hsieh
Journal:  Urol Pract       Date:  2017-03-27

7.  Proceedings of the Working Group Session on Fertility Preservation for Individuals with Gender and Sex Diversity.

Authors:  Courtney Finlayson; Emilie K Johnson; Diane Chen; Elizabeth Dabrowski; Yasmin Gosiengfiao; Lisa Campo-Engelstein; Ilina Rosoklija; Jill Jacobson; Margarett Shnorhavorian; Mary Ellen Pavone; Molly B Moravek; Herbert J Bonifacio; Lisa Simons; Janella Hudson; Patricia Y Fechner; Veronica Gomez-Lobo; Rachel Kadakia; Angela Shurba; Erin Rowell; Teresa K Woodruff
Journal:  Transgend Health       Date:  2016-06-01

8.  The Ethics of Fertility Preservation for Pediatric Patients With Differences (Disorders) of Sex Development.

Authors:  Lisa Campo-Engelstein; Diane Chen; Arlene B Baratz; Emilie K Johnson; Courtney Finlayson
Journal:  J Endocr Soc       Date:  2017-06-01

9.  Ethical, moral and other aspects related to fertility preservation in cancer patients.

Authors:  Bruno Ramalho de Carvalho; Jhenifer Kliemchen; Teresa K Woodruff
Journal:  JBRA Assist Reprod       Date:  2017-02-01

10.  Advancement of male health is dependent upon updates to insurance coverage for infertility in the United States.

Authors:  Ryan P Smith; Larry I Lipshultz; Jason R Kovac
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.